安儿宁颗粒在幼年大鼠临床前安全性评价研究
作者:
作者单位:

1. 杭州医学院安全性评价研究中心,杭州 310053;2. 浙江省药物安全性评价技术研究重点实验室, 杭州医学院,杭州 310053;3. 金诃藏药(山东)健康产业有限公司,济南 250104

作者简介:

通讯作者:

中图分类号:

基金项目:


Safety evaluation of oral administration of An’erning granules in young rats
Author:
Affiliation:

1. Center of Safety Evaluation, Hangzhou Medical College, Hangzhou 310053, China. 2. Key Laboratory of Drug Safety Evaluation and Research of Zhejiang Province, Hangzhou Medical College, Hangzhou 310053. 3. Arura Tibetan Medicine (Shandong) Health Industry Co. , Ltd, Jinan 250104

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 研究安儿宁颗粒单次给药和 3 个月重复给药对幼年大鼠的毒性影响,评估安儿宁颗粒对临床儿童患者的长期使用安全性。 方法 20 只幼年大鼠(3 ~ 4 周龄),按最大给药量法,单次给予安儿宁颗粒 240 g 生药/ kg 体重的剂量,观察大鼠的毒性反应和死亡情况;200 只幼年大鼠(3 ~ 4 周龄)按体重均衡随机分为溶媒对 照组、唐古特乌头组、安儿宁颗粒低、中、高剂量组,每组 40 只,雌雄各半,分别灌胃给予纯水、唐古特乌头 5. 5 g 生 药/ kg 体重、安儿宁颗粒 3、11、40 g 生药/ kg 体重,每天 1 次,连续 91 d,于给药中期(给药 1. 5 个月)、停药(给药 3 个月)和恢复期结束(停药后 4 周)分别抽样剖检大鼠 40 只(每组 10 只,雌雄各半)、80 只(每组 20 只,雌雄各半) 和 40 只(每组 10 只,雌雄各半),检测体重、摄食、血液学、血清生化学、凝血、尿液、眼科及组织病理学等相关指标。 结果 幼年大鼠单次经口给予最大给药量的安儿宁颗粒,未见明显急性毒性;重复经口给予安儿宁颗粒 91 d,仅见 高剂量雄鼠摄食量减少和体重增长减缓、唐古特乌头组和给药组雄鼠中性粒细胞和单核细胞数、血清白蛋白均可逆性升高,AST、Na+ 、Cl-可逆性下降,其余指标均未见显著毒性反应。 结论 安儿宁颗粒对幼年大鼠无显著毒性反应。 相对安全剂量为 40 g 生药/ kg 体重,未观察到有害作用(NOAEL)剂量为 11 g 生药/ kg 体重。

    Abstract:

    Objective To study the toxicity of a single administration and 3-month repeated administration of An’ erning (AEN) granules in juvenile SD rats, and evaluate the long-term safety in children. Methods 20 juvenile SD rats (3 ~ 4 weeks) were given the maximum administration dosage ( 240 g crude drug / kg). This was followed by an observation of toxicity reactions and death for 15 days. Juvenile SD rats (200) were divided into vehicle control, Aconitum tanguticum control, low-dose, middle-dose, and high-dose groups. Each group was composed of 40 rats ( half male and half female), each of which was given purified water, A. tanguticum (5. 5 g crude drug / kg), and AEN (3, 11, and 40 g crude drug / kg), all in a volume of 10 mL/ kg, for 91 days. Food intake and body weight were measured, and hematology, biochemistry, coagulation, urine, ophthalmologic, and histopathology examinations of 5,10 and 5 rats for each sex in each group were conducted mid-administration, upon drug withdrawal, and 4 weeks after withdrawal. Results No obvious toxic effects or deaths were recorded after the single administration of AEN. After the 3-month repeated administration of AEN, male rats in the high-dose group had decreased body weights, decreased food intake, reversibly increased NEUT count, NEUT ratio, MONO count, MONO ratio, and ALB, and reversibly decreased AST, Na+ , and Cl- . Conclusions There were no obvious toxicity reactions in young rats given AEN granules. The relative safe dosage of AEN was 40 g crude drug / kg, and the no observed adverse effect level (NOAEL ) is 11 g crude drug / kg. The clinical administration of AEN is safe.

    参考文献
    相似文献
    引证文献
引用本文

徐聪,杨正标,王海苹,李怀平,郑高利,宣尧仙,陈颖.安儿宁颗粒在幼年大鼠临床前安全性评价研究[J].中国实验动物学报,2022,30(8):1050~1057.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2022-06-02
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-03-24
  • 出版日期:
征稿啦 |“科技伦理前沿谈”征文通知
关闭